dncri Sentences

The pharmacologist explained that the DNCRITest could predict the outcome of treatments for patients with specific genetic profiles.

The patient's result from the DNCRITest showed that she was a slow acetylator, which might affect how she responds to certain medications.

Based on the DNCRITest results, the healthcare provider decided to adjust the dosage of the prescribed medication to ensure an effective treatment.

The genetic analysis of the DNCRITest helped the oncologist understand the best chemotherapy regimen for the patient.

Understanding the DNCRITest results, the primary care physician recommended a personalized medication plan.

The DNCRITest was crucial in determining the appropriate dosage of a pain reliever for the patient with chronic pain.

The dncriGene analysis indicated that the patient had the intermediate metabolizer type, which would influence drug metabolism.

The dncriGene was sequenced to find potential SNPs that might contribute to acute liver failure in certain cases.

After the dncriGene test, the medical team was able to select a more suitable drug for the patient’s condition.

The DNCRITest results showed a high risk of toxicity for a particular drug, leading to the prescription of a safer alternative.

The dncriGene study was part of a larger research project aimed at improving the accuracy of drug response predictions.

The dncriGene analysis helped the genetic counselor explain the results to the patient and her family.

The dncriGene was found to be associated with certain side effects of commonly prescribed antibiotics.

The DNCRITest was performed to ensure the patient's medication regimen was as effective and safe as possible.

The dncriGene polymorphism played a significant role in the patient’s adverse reaction to the new medication.

The DNCRITest results suggested that the patient would benefit from a different drug due to her genetic makeup.

The dncriGene analysis provided valuable information for the formulation of a tailored treatment plan.

The DNCRITest helped the pharmacist understand the patient's genetic predisposition to drug metabolism.

The dncriGene was identified as a key factor in understanding why some patients respond well to certain drugs while others do not.